ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

TRVN Company Profile and Key Details

OTC : TRVN

Trevena, Inc.

$1.20

-0.04-3.23%

Open: 3:51 PM

69.17

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

TRVN Stock Price Chart

Stock Price Today

Trevena, Inc. (TRVN) stock declined over -3.23%, trading at $1.20 on OTC, down from the previous close of $1.24. The stock opened at $1.20, fluctuating between $1.20 and $1.20 in the recent session.

Stock Snapshot

1.24

Prev. Close

1.2

Open

1.04M

Market Cap

863.79K

Number of Shares

1.2

Day Low

1.2

Day High

-0.02

P/E Ratio

97.85%

Free Float in %

-48.89

EPS (TTM)

0.25

Book Value

-2.7

Cash Flow per Share

100

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Apr 04, 2025	1.20	1.20	1.20	1.20	100
Apr 02, 2025	1.24	1.29	1.18	1.28	533
Apr 01, 2025	1.22	1.26	1.22	1.26	236
Mar 28, 2025	1.27	1.27	1.20	1.20	853
Mar 27, 2025	1.34	1.34	1.29	1.29	900
Mar 26, 2025	1.34	1.34	1.26	1.28	1K
Mar 25, 2025	1.40	1.40	1.39	1.39	400
Mar 24, 2025	1.28	1.28	1.28	1.28	0
Mar 21, 2025	1.37	1.38	1.28	1.28	1.2K
Mar 19, 2025	1.25	1.32	1.25	1.32	1K
Mar 18, 2025	1.30	1.30	1.25	1.30	543
Mar 17, 2025	1.17	1.30	1.17	1.30	2K
Mar 14, 2025	1.55	1.55	1.26	1.36	1.1K
Mar 13, 2025	1.27	1.55	1.26	1.55	3.21K
Mar 12, 2025	1.51	1.51	1.51	1.51	8
Mar 11, 2025	1.38	1.51	1.36	1.48	2.4K
Mar 10, 2025	1.55	1.55	1.51	1.51	526
Mar 07, 2025	1.54	1.54	1.54	1.54	200
Mar 06, 2025	1.71	1.71	1.71	1.71	900
Mar 05, 2025	1.51	1.74	1.51	1.74	402

Contact Details

Chesterbrook, PA 19087

United States

Website: https://www.trevena.comContact: 610 354 8840

About Company

Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV027 for the treatment of acute lung injury contributing to acute respiratory distress syndrome and abnormal blood clotting in patients with COVID-19; TRV250, a G protein biased delta-opioid receptor agonist for the treatment of acute migraine; TRV734, a small molecule G protein biased ligand of the MOR for the treatment of moderate-to-severe acute and chronic pain; and TRV045, a novel S1P modulator for managing chronic pain. The company has a collaboration with Imperial College London to evaluate Trv027 in Covid-19 patients. Trevena, Inc. was incorporated in 2007 and is headquartered in Chesterbrook, Pennsylvania.

Frequently Asked Questions

What is the current Trevena, Inc. (TRVN) stock price?

Trevena, Inc. (NASDAQ: TRVN) stock price is $1.20 in the last trading session. During the trading session, TRVN stock reached the peak price of $1.20 while $1.20 was the lowest point it dropped to. The percentage change in TRVN stock occurred in the recent session was -3.23% while the dollar amount for the price change in TRVN stock was -$0.04.

TRVN's industry and sector of operation?

The NASDAQ listed TRVN is part of Biotechnology industry that operates in the broader Healthcare sector. Trevena, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of TRVN?

Ms. Carrie L. Bourdow
Pres, Chief Executive Officer & Director
Mr. Michael Catalano
Vice President of Marketing
Mr. Barry Shin
Senior Vice President & Chief Financial Officer
Ms. Patricia M. Drake
Senior Vice President & Chief Commercial Officer
Mr. Joel Solomon
Vice President, Gen. Counsel & Chief Compliance Officer
Mr. Robert T. Yoder
Senior Vice President, Chief Bus. Officer & Head of Commercial Operations
Dr. Mark A. Demitrack
Senior Vice President & Chief Medical Officer
Dr. Howard A. Rockman M.D.
Scientific Founder, Consultant and Member of Scientific Advisory Board

How TRVN did perform over past 52-week?

TRVN's closing price is 6.2% higher than its 52-week low of $1.13 where as its distance from 52-week high of $11.25 is -89.33%.

How many employees does TRVN have?

Number of TRVN employees currently stands at 23.

Link for TRVN official website?

Official Website of TRVN is: https://www.trevena.com

How do I contact TRVN?

TRVN could be contacted at phone 610 354 8840 and can also be accessed through its website. TRVN operates from 955 Chesterbrook Boulevard, Chesterbrook, PA 19087, United States.

How many shares of TRVN are traded daily?

TRVN stock volume for the day was 100 shares. The average number of TRVN shares traded daily for last 3 months was 2.31K.

What is the market cap of TRVN currently?

The market value of TRVN currently stands at $1.04M with its latest stock price at $1.20 and 863.79K of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

Employees	23
Beta	1.04
Sales or Revenue	-$418.00K
5Y Sales Change%	1.171%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology